🎙️ Podcast Overview
- Episode Title: Common Medications and Diabetic Macular Edema
- Guests: Jawad Muayad (Texas A&M) and Dr. Sami S. Dahr (UT Health Sciences Center)
- Host: Dr. Drew Carey (Johns Hopkins Wilmer Eye Institute)
- Journal Article Discussed: “Influence of Common Medications on Diabetic Macular Edema in Type 2 Diabetes Mellitus” (Ophthalmology Retina, Vol. 9, Issue 6)
🧪 Study Focus
- Investigated the impact of systemic medications on the risk of developing DME in patients with type 2 diabetes.
- Medications studied:
- GLP-1 receptor agonists
- Fenofibrates
- Thiazolidinediones (glitazones)
- Calcium channel blockers
📊 Methodology
- Used the TriNetX database for comprehensive EHR access across institutions.
- Inclusion criteria:
- Type 2 diabetics newly initiated on one of the four medications
- No prior diabetic eye disease
- Minimum five-year diabetes history
- At least two follow-up prescriptions
- Propensity score matching for:
- A1C levels
- Diabetes complication severity index
- Medication-specific indications
📈 Key Findings
| Medication | Impact on DME Risk | Notes |
|---|---|---|
| Calcium channel blockers | ↑ 66% risk | Significant increase |
| GLP-1 receptor agonists | ↓ ~20% risk | Statistically significant |
| Fenofibrates | ↓ ~20% risk | Statistically significant |
| Thiazolidinediones | No significant change | Contrasts with older studies |
💡 Clinical Implications
- Calcium channel blockers: May warrant reconsideration or closer monitoring in DME patients.
- GLP-1s: Despite FDA label warnings, may offer protective effects over time.
- Practice Change: Dr. Dahr now reviews systemic medications in suboptimal anti-VEGF responders and may recommend changes.
🔍 Future Directions
- Prospective trials to assess whether GLP-1s improve response to anti-VEGF therapy.
- Explore complex medication interactions (e.g., glitazones with insulin).
🗓️ Upcoming Events
- Virtual Journal Club: August 27, 2025 — discussion on GLP-1 use in non-diabetic patients and glaucoma risk.
- AAO 2025 Illuminate Event: October 18, 2025 — social gathering supporting ophthalmic education.
